November 2011
Several years ago, we developed a cancer eating bacteria that is incapable of causing disease and that carries an immune stimulant gene directly into tumors. With one oral dose we have seen 60% to 90% tumor destruction without any apparent side effects in several animal models of primary and metastatic cancers. This genetically engineered bacteria is currently undergoing a clinical human trial here at the University of Minnesota
with very promising initial results. In fact, we have been the only lab at the University of Minnesota in the last 25 years to literally take a cancer drug from “lab bench to bedside”.
Our laboratory is now focused on developing the next generation of engineered cancer killing bacteria and we strongly believe we are on the cusp of developing a strategy to impart an even greater cancer killing effect. With the downturn in the economy, many of the traditional sources of medical research funding have been severely affected. Furthermore, our research endeavors represent some very “out of the box” thinking that the traditional chemotherapy touting physicians have not embraced. It is obvious that using one’s own immune system to kill cancer is where we need to focus our efforts rather than develop yet another severely toxic drug that sometimes is worse than the disease itself.
My mom was diagnosed with a form of lung cancer in 1998 they gave her six months to live. They started chemo treatments. well the cancer was greatly reduced and she fought it for awhile until they found tumers in her brain. Then they started chemo and radiation treatments then it was 3 brain surgerys there was no surgey for the lung cancer. I am a firm beliver the chemo was the cause of the tumors in her brain. My mom passed awy in 2004. The chemo and radiation bought us more time but her death was all but painless and quick. she suffered for several months with loss of memory. She got to the point she did not even know who I was that was the hardest. Please keep up the fight i beleive n your work. thank you.